IP Library › Assignment 030678/0620
Patent Assignment
Reel/Frame 030678/0620

Security Agreement

Recorded: 2013-06-25 Pages: 9
Assignor
KADMON PHARMACEUTICALS, LLC
Executed: 2013-06-17
Assignee
MACQUARIE US TRADING LLC
225 WEST WASHINGTON STREET, 21ST FLOOR, CHICAGO, ILLINOIS, 20036-1564
Covered Properties (10)
Microbial Production of Mature Human Leukocyte Interferons
Patent: 6,610,830 →
Application: 06/256,204 →
N-Terminally Chemically Modified Protein Compositions and Methods
Patent: 5,824,784 →
Application: 08/321,510 →
Methods for Retreatment of Patients Afflicted with Hepatitis C Using Consensus Interferon
Patent: 5,980,884 →
Application: 08/595,440 →
Use of the Human Interferon Consensus Gene for Gene Therapy
Patent: 5,831,062 →
Application: 08/852,889 →
N-Terminally Chemically Modified Protein Compositions and Methods
Patent: 5,985,265 →
Application: 08/879,760 →
Treatment of Multiple Sclerosis Using Consensus Interferon and Il-1 Receptor Antagonist
Patent: 6,013,253 →
Application: 08/911,893 →
Curing Accelerator and Resin Composition
Patent: 6,428,613 →
Application: 09/585,324 →
Process for Producing Wet Ribavirin Pellets
Patent: 6,720,000 →
Application: 09/812,024 →
Publication: US 2003/0018000
Composition Containing Ribavirin and Use Thereof
Patent: 7,538,094 →
Application: 10/882,358 →
Publication: US 2005/0019406
Large Dose Ribavirin Formulations
Patent: 7,723,310 →
Application: 11/201,311 →
Publication: US 2006/0083785
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 22, 2010
From: KINSTLER, OLAF B.; GABRIEL, NANCY E.; FARRAR, CHRISTINE E.; DEPRINCE, RANDOLPH B.
To: AMGEN INC.
Reel/Frame 023832/0672 →
Security Agreement Jun 25, 2013
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030678/0514 →
Release of Security Interest Aug 31, 2015
From: MACQUARIE US TRADING LLC
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 036461/0825 →
Security Interest Aug 31, 2015
From: KADMON PHARMACEUTICALS, LLC
To: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
Reel/Frame 036460/0811 →
Security Interest Sep 2, 2015
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 036478/0611 →
Change of Name Feb 3, 2016
From: THREE RIVERS PHARMACEUTICALS, LLC
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 037690/0466 →
Termination of Patent and Trademark Security Agreement Nov 25, 2019
From: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 051106/0789 →
Assignment of Assignor's Interest Jul 26, 2022
From: KADMON PHARMACEUTICALS, LLC
To: CHARTWELL PHARMACEUTICALS LLC
Reel/Frame 060622/0317 →